James’ research focuses on understand the extreme genomic complexity of high-grade serous ovarian cancer, as this is the major barrier to choosing better personalized treatments for patients and to understand why ovarian cancer is so difficult to treat. His research spans approaches to improve understanding of the biology of ovarian cancer, discover better tests for blood and tissue samples and translation of these findings into new trials and into the clinic. This work is underpinned by his clinical practice as a medical oncologist specializing in ovarian cancer.
